410P Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study (Q115221974)
Jump to navigation
Jump to search
scientific article published in 2022
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 410P Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study |
scientific article published in 2022 |
Statements
410P Prognostic value of baseline ECOG performance status, frailty phenotype, and geriatric screening tools (G8 and VES-13) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study (English)
G. Liposits
J. Ryg
H. Skuladottir
S.B. Winther
S. Möller
E. Hofsli
C-H. Shah
L. Poulsen Oestergaard
A. Berglund
C. Qvortrup
P.J. Osterlund
B. Glimelius
H. Sorbye
P. Pfeiffer
September 2022
33
S723